| Previous Close | 0.0300 |
| Open | 0.0300 |
| Bid | 0.0300 x 0 |
| Ask | 0.0350 x 0 |
| Day's Range | 0.0300 - 0.0300 |
| 52 Week Range | 0.0150 - 0.0850 |
| Volume | 271,700 |
| Avg. Volume | 173,093 |
| Market Cap | 2.814M |
| Beta (5Y Monthly) | 1.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0130 |
| Earnings Date | Jul. 02, 2020 - Jul. 06, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 461.63 |
- ACCESSWIRE
Cylix Data And Eastwest Announce Reverse Takeover Transaction Of 1264136 B.C. Ltd. By Cylix Data And Brokered Financing Led By Canaccord
PENTICTON, BC / ACCESSWIRE / April 12, 2021 / EastWest Bioscience Inc.V:EAST) ("EastWest" or the "Company") and 2747524 Ontario Inc.
- ACCESSWIRE
EastWest Bioscience Announces Shares for Debt Settlement
VANCOUVER, BC / ACCESSWIRE / April 8, 2021 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSXV:EAST) announces the issuance of 3,777,567 common shares at a price of CDN $0.
- ACCESSWIRE
EastWest Bioscience Posts Triple Digit Growth in Quarterly Manufacturing Revenue; Continues Reduction of G&A Expenses
PENTICTON, BC / ACCESSWIRE / March 29, 2021 / EastWest Bioscience (the "Company" or "EastWest") (TSXV:EAST), a vertically integrated wellness holding company that owns manufacturing facility with retail presence across Canada, reported its financial results for the three and six months ended January 31, 2021. All figures are reported in Canadian dollars unless otherwise indicated.
© 2021 Verizon Media. All rights reserved.
